252 related articles for article (PubMed ID: 34905407)
1. Controlling the Burden of COVID-19 by Manipulating Host Metabolism.
Miller L; Berber E; Sumbria D; Rouse BT
Viral Immunol; 2022; 35(1):24-32. PubMed ID: 34905407
[TBL] [Abstract][Full Text] [Related]
2. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
Lindholm PF; Ramsey G; Kwaan HC
Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
[TBL] [Abstract][Full Text] [Related]
3. Virus Infections and Host Metabolism-Can We Manage the Interactions?
Sumbria D; Berber E; Mathayan M; Rouse BT
Front Immunol; 2020; 11():594963. PubMed ID: 33613518
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship.
Oberemok VV; Laikova KV; Yurchenko KA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Jul; 69(7):635-640. PubMed ID: 32350571
[TBL] [Abstract][Full Text] [Related]
5. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.
Low ZY; Zabidi NZ; Yip AJW; Puniyamurti A; Chow VTK; Lal SK
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146796
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming and immune regulation in viral diseases.
Ganesh GV; Mohanram RK
Rev Med Virol; 2022 Mar; 32(2):e2268. PubMed ID: 34176174
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
10. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
Akaji K; Konno H
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
[TBL] [Abstract][Full Text] [Related]
11. A Game of Infection - Song of Respiratory Viruses and Interferons.
Wang GQ; Gu Y; Wang C; Wang F; Hsu AC
Front Cell Infect Microbiol; 2022; 12():937460. PubMed ID: 35846766
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD.
Chen H; Chen Q
Int J Biol Sci; 2022; 18(12):4756-4767. PubMed ID: 35874945
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: Prospective Challenges and Potential Vaccines.
Shahid Nadeem M; Ali A; Al-Ghamdi MA; Depfenhart M; Azam Khan J; Zamzami MA; Nazia Murtaza B; Kazmi I; Ur Rehman M
Altern Ther Health Med; 2020 Aug; 26(S2):72-78. PubMed ID: 32845250
[TBL] [Abstract][Full Text] [Related]
14. Return-to-work, disabilities and occupational health in the age of COVID-19.
Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
[TBL] [Abstract][Full Text] [Related]
15. Autophagy/virophagy: a "disposal strategy" to combat COVID-19.
Mijaljica D; Klionsky DJ
Autophagy; 2020 Dec; 16(12):2271-2272. PubMed ID: 32578486
[TBL] [Abstract][Full Text] [Related]
16. Arginine depletion as a therapeutic approach for patients with COVID-19.
Grimes JM; Khan S; Badeaux M; Rao RM; Rowlinson SW; Carvajal RD
Int J Infect Dis; 2021 Jan; 102():566-570. PubMed ID: 33160064
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer.
Knight TE
Biopreserv Biobank; 2020 Dec; 18(6):492-502. PubMed ID: 32726140
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Vaccines and therapeutics.
Ponnampalli S; Venkata Suryanarayana Birudukota N; Kamal A
Bioorg Med Chem Lett; 2022 Nov; 75():128987. PubMed ID: 36113669
[TBL] [Abstract][Full Text] [Related]
19. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
Zhou H; Ni WJ; Huang W; Wang Z; Cai M; Sun YC
Front Immunol; 2022; 13():834942. PubMed ID: 35450063
[TBL] [Abstract][Full Text] [Related]
20. Dissecting lipid metabolism alterations in SARS-CoV-2.
Casari I; Manfredi M; Metharom P; Falasca M
Prog Lipid Res; 2021 Apr; 82():101092. PubMed ID: 33571544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
